Cardinal Health, Inc.
https://www.cardinalhealth.com/en.html
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Cardinal Health, Inc.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
OKYO Hits Multiple Dry Eye Endpoints, Plans Move Into Phase III
OKYO’s eye drop OK-101 has hit endpoints for ocular pain, tear film breakup time and conjunctival staining in Phase II, while demonstrating a placebo-like tolerability profile.
Andera Reflects On Revitalized Biotech Scene
After AstraZeneca’s acquisition of Amolyt made the Paris-based investment group a tidy profit, Andera spoke to Scrip about the rejuvenated investment market in Europe.
News We’re Watching: First OTC Blood Glucose Monitor, Recalls For Ventec and Medtronic, Guidance Docs Under White House Review
This week, the US FDA announced that it had cleared Dexcom’s Stelo Glucose Biosensor System, making it the first OTC device of its type available in the US. Additionally, the Office of Management and Budget took up guidance documents on cybersecurity and enforcement on diagnostics during emergencies, and recalls were announced by Medtronic, Ventec and Cardinal.
Company Information
- Industry
- Contract Research, Toxicology Testing-CRO
- Distributors
- Medical Devices
- Services
-
Services
- Home Infusion
- Hospitals, Nursing Homes, Institutions
- Pharmacy Services, PBMs
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
-
Drug Delivery
- Other Names / Subsidiaries
-
- AccessClosure
- Allegiance Healthcare Corporation
- Cordis Corporation
- Innovative Therapies, naviHealth
- OutcomesMTM
- The Harvard Drug Group
- VIASYS Healthcare
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice